EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Therapeutic potential of natural compounds in the management of chronic diseases: Targeting PINK1–Parkin pathway

Naglaa F Khedr, Hend M Selim, Gamal A Abourayya

Pathology - Research and Practice · 2026-01 · 277 · 156284

DOI: 10.1016/j.prp.2025.156284 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2026-01. Verfasst von Naglaa F Khedr und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Tanta University, Al-Geish Street, Tanta, El-Gharbia 31527, Egypt. Electronic address: Naglaa.khedr@…. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Signal Transduction, Protein Kinases, Biological Products. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 135 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic diseases like neurodegenerative disorders, musculoskeletal issues, metabolic diseases, cancer, liver and kidney disorders are increasingly linked to mitochondrial dysfunction. PINK1-Parkin-mediated mitophagy, a vital autophagic process, plays a central role in maintaining cellular homeostasis by selectively eliminating damaged mitochondria, which is crucial for preserving mitochondrial integrity and preventing reactive oxygen species accumulation. Activation of the PINK1-Parkin signaling pathway has emerged as a promising therapeutic strategy to restore mitochondrial function and attenuate disease progression. Recent studies have demonstrated that natural PINK1-Parkin activators offer significant therapeutic potential for treating a wide range of chronic diseases by modulating mitochondrial dynamics, alleviating cellular inflammation, and preventing mitochondrial damage. This review provides an in-depth analysis of the molecular mechanisms underlying PINK1-Parkin signaling, discusses the therapeutic benefits of natural activators, and presents them as a compelling strategy for addressing mitochondrial dysfunction and mitigating the progression of chronic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesSignal TransductionProtein KinasesBiological ProductsHumansChronic DiseaseAnimalsMitochondriaMitophagyPTEN-Induced Putative Kinase

Stichwörter der Autor:innen

Chronic liver diseasesMitophagyMusculoskeletal DisordersNeurodegenerative disordersPINK1Parkin

Substanzen

Ubiquitin-Protein LigasesProtein KinasesBiological ProductsPTEN-Induced Putative Kinaseparkin protein

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Tanta University, Al-Geish Street, Tanta, El-Gharbia 31527, Egypt. Electronic address: Naglaa.khedr@pharm.tanta.edu.eg.
  • Department of Biochemistry, Faculty of Pharmacy, Tanta University, Al-Geish Street, Tanta, El-Gharbia 31527, Egypt. Electronic address: Hend.m.selim@pharm.tanta.edu.eg.
  • Department of Biochemistry, Faculty of Pharmacy, Tanta University, Al-Geish Street, Tanta, El-Gharbia 31527, Egypt. Electronic address: Gamal.zaki@pharm.tanta.edu.eg.

Zitieren

APA

Khedr, N. F., Selim, H. M., & Abourayya, G. A. (2026). Therapeutic potential of natural compounds in the management of chronic diseases: Targeting PINK1–Parkin pathway. Pathology - Research and Practice, 277, 156284. https://doi.org/10.1016/j.prp.2025.156284

Vancouver

Khedr NF, Selim HM, Abourayya GA. Therapeutic potential of natural compounds in the management of chronic diseases: Targeting PINK1–Parkin pathway. Pathology - Research and Practice. 2026;277:156284. doi:10.1016/j.prp.2025.156284

BibTeX
@article{Khedr2026,
  author = {Khedr, Naglaa F and Selim, Hend M and Abourayya, Gamal A},
  title = {Therapeutic potential of natural compounds in the management of chronic diseases: Targeting PINK1–Parkin pathway},
  journal = {Pathology - Research and Practice},
  year = {2026},
  volume = {277},
  pages = {156284},
  doi = {10.1016/j.prp.2025.156284}
}
Kostenlos starten →